-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Loviride
Category | Human immunodeficiency Virus (HIV) |
CAS | 147362-57-0 |
Description | Loviride is an RNA-directed DNA polymerase inhibitor potentially for the treatment of HIV infection. |
Product Information
Synonyms | R 89439; R-89439; alpha-APA; (+-)-2-(6-Acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide |
IUPAC Name | 2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide |
Molecular Weight | 351.23 |
Molecular Formula | C17H16Cl2N2O2 |
Canonical SMILES | CC1=CC(=C(C=C1)C(=O)C)NC(C2=C(C=CC=C2Cl)Cl)C(=O)N |
InChI | InChI=1S/C17H16Cl2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23) |
InChIKey | CJPLEFFCVDQQFZ-UHFFFAOYSA-N |
Boiling Point | 550.3±50.0 °C at 760 mmHg |
Melting Point | 226.3°C |
Flash Point | 286.6°C |
Purity | 99% |
Density | 1.44 g/cm3 |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Light yellow to yellow (Solid) |
Storage | Store at -20°C |
Complexity | 436 |
Exact Mass | 350.0588831 |
Index Of Refraction | 1.637 |
In Vitro | Loviride (0.01 µM) inhibits HIV-1(IIIB) replication in MT-4 cells, also inhibits HIV-2 and SIV, with EC50s of 85.5, 7.4 µM for HIV-2 (ROD), HIV-2 (EHO), and 11.4, 28.5, 57.0 µM for SIV (mac251), SIV (agm3), SIV (mndGB1), respectively. |
PSA | 73.18000 |
Target | Reverse Transcriptase; HIV |
Vapor Pressure | 3.69E-12mmHg at 25°C |
XLogP3-AA | 4.4 |